SVA
Sinovac Biotech, Ltd.

762
Mkt Cap
$460.27M
Volume
0.00
52W High
$6.47
52W Low
$6.47
Price
$6.47
SVA Fundamentals
Prev Close
$6.49
Open
$6.47
50D MA
$6.47
Beta
0.00
Avg. Volume
0.00
Loading...
Loading...
News
all
press releases
News Placeholder
Sinovac:Antigua Court Makes Interim Order Giving Board Control of the Company until the Trial of the Disputed 2025 Shareholder Meeting
Sinovac Biotech Ltd. (NASDAQ: SVA) (SINOVAC or the Company), a leading provider of biopharmaceutical products in China, today announced that the Antigua High Court has ordered that the directors Mr...
Business Wire·12d ago
News Placeholder
SINOVAC Announces Receipt of Nasdaq Notice of Delisting and Intention to Appeal
Sinovac Biotech Ltd. (Nasdaq: SVA) (SINOVAC or the Company), a leading provider of biopharmaceutical products in China, announced today that on November 12, 2025, it received a delisting...
Business Wire·1mo ago
News Placeholder
Independent Sinovac Shareholders Express Strong Support for Immediate Dividend Payment
Independent Sinovac Shareholders Express Strong Support for Immediate Dividend Payment Independent Sinovac Shareholders Express Strong Support for Immediate Dividend Payment PR Newswire BOSTON, Nov...
PR Newswire·2mo ago
News Placeholder
Sinovac Clears Legal Hurdle In Control Battle, Moves Forward With $55 Dividend
A U.S. court denied an emergency injunction sought by dissenting investors, while a separate case in Antigua could unlock an additional $11 per share if disputed PIPE shares are invalidated.
Stocktwits·6mo ago
<
...
1
>

Latest SVA News

View

Advertisement|Remove ads.

Advertisement|Remove ads.